-
EP2804623
European procedure
Extract from the Register of European Patents
EP About this file: EP2804623
| EP2804623 - CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.07.2020 Database last updated on 12.07.2024 | |
| Former | The patent has been granted Status updated on 05.07.2019 | ||
| Former | Grant of patent is intended Status updated on 10.02.2019 | ||
| Former | Examination is in progress Status updated on 08.01.2019 | ||
| Former | Grant of patent is intended Status updated on 07.06.2018 | ||
| Former | Examination is in progress Status updated on 07.11.2016 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Bioverativ Therapeutics Inc. 225 Second Avenue Waltham, MA 02451 / US | [2017/28] |
| Former [2015/29] | For all designated states Biogen MA Inc. 250 Binney Street Cambridge, MA 02142 / US | ||
| Former [2014/48] | For all designated states Biogen Idec MA Inc. 14 Cambridge Center Cambridge, MA 02142 / US | Inventor(s) | 01 /
CHHABRA, Ekta, Seth 175 Arthur Street Framingham, MA 01702 / US | 02 /
LIU, Tongyao 53 Buckman Drive Lexington, MA 02421 / US | 03 /
PETERS, Robert 51 Newfield street West Roxbury, MA 02132 / US | 04 /
JIANG, Haiyan 3 Bayberry Lane Belmont Massachusetts 02478 / US | [2015/03] |
| Former [2014/48] | 01 /
CHHABRA, Ekta, Seth 1550 Worcester Road (Unit 128) Framingham, MA 01702 / US | ||
| 02 /
LIU, Tongyao 53 Buckman Drive Lexington, MA 02421 / US | |||
| 03 /
PETERS, Robert 51 Newfield street West Roxbury, MA 02132 / US | |||
| 04 /
JIANG, Haiyan 3 Bayberry Lane Belmont Massachusetts 02478 / US | Representative(s) | Zwicker, Jörk, et al ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [N/P] |
| Former [2014/48] | Miller, David James, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | Application number, filing date | 13735649.9 | 12.01.2013 | [2019/32] | WO2013US21330 | Priority number, date | US201261586099P | 12.01.2012 Original published format: US 201261586099 P | US201261586654P | 13.01.2012 Original published format: US 201261586654 P | US201261667901P | 03.07.2012 Original published format: US 201261667901 P | US201261734954P | 07.12.2012 Original published format: US 201261734954 P | [2014/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013106787 | Date: | 18.07.2013 | Language: | EN | [2013/29] | Type: | A1 Application with search report | No.: | EP2804623 | Date: | 26.11.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.07.2013 takes the place of the publication of the European patent application. | [2014/48] | Type: | B1 Patent specification | No.: | EP2804623 | Date: | 07.08.2019 | Language: | EN | [2019/32] | Search report(s) | International search report - published on: | US | 18.07.2013 | (Supplementary) European search report - dispatched on: | EP | 03.11.2015 | Classification | IPC: | A61K38/37, C07K14/755, C07K16/00, A61K47/62 | [2018/24] | CPC: |
C07K14/755 (EP,EA,IL,KR,US);
C07K19/00 (IL,KR);
A61K38/37 (EP,EA,IL,KR,US);
A61K47/50 (IL,KR);
A61K47/62 (EP,IL,US);
A61P7/04 (EP,IL);
C07K16/00 (IL,US);
C12N15/62 (IL,KR);
C12N15/63 (EA,IL);
|
| Former IPC [2014/48] | A61K38/37 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/48] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | CHIMÄRE FAKTOR-VII POLYPEPTIDE UND VERWENDUNGEN DAVON | [2014/48] | English: | CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF | [2014/48] | French: | FACTEUR VIII CHIMÉRIQUE ET POLYPEPTIDES ET LEURS UTILISATIONS | [2014/48] | Entry into regional phase | 12.08.2014 | National basic fee paid | 12.08.2014 | Search fee paid | 12.08.2014 | Designation fee(s) paid | 12.08.2014 | Examination fee paid | Examination procedure | 12.08.2014 | Examination requested [2014/48] | 25.05.2016 | Amendment by applicant (claims and/or description) | 07.07.2016 | Despatch of a communication from the examining division (Time limit: M06) | 17.01.2017 | Reply to a communication from the examining division | 11.12.2017 | Despatch of a communication from the examining division (Time limit: M04) | 15.03.2018 | Reply to a communication from the examining division | 08.06.2018 | Communication of intention to grant the patent | 27.11.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 02.01.2019 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 11.02.2019 | Communication of intention to grant the patent | 21.06.2019 | Fee for grant paid | 21.06.2019 | Fee for publishing/printing paid | 21.06.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP18211179.9 / EP3505179 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.07.2016 | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/33] | Request for further processing for: | The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent | 02.01.2019 | Request for further processing filed | 02.01.2019 | Full payment received (date of receipt of payment) Request granted | 21.01.2019 | Decision despatched | Fees paid | Renewal fee | 27.01.2015 | Renewal fee patent year 03 | 27.01.2016 | Renewal fee patent year 04 | 27.01.2017 | Renewal fee patent year 05 | 15.01.2018 | Renewal fee patent year 06 | 31.01.2019 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 07.08.2019 | MK | 07.08.2019 | SM | 07.08.2019 | IS | 07.12.2019 | [2022/32] |
| Former [2020/36] | AL | 07.08.2019 | |
| SM | 07.08.2019 | ||
| IS | 07.12.2019 | ||
| Former [2020/28] | AL | 07.08.2019 | |
| SM | 07.08.2019 | ||
| IS | 24.02.2020 | ||
| Former [2020/24] | AL | 07.08.2019 | |
| IS | 24.02.2020 | ||
| Former [2020/15] | AL | 07.08.2019 | |
| IS | 07.12.2019 | ||
| Former [2020/14] | IS | 07.12.2019 | Documents cited: | Search | [XY]EP1935430 (CSL BEHRING GMBH [DE]) [X] 1,3,5,6,8,11-16 * paragraphs [0015] - [0017] * * paragraphs [0024] , [0028] , [0029] , [0037] * * paragraphs [0041] - [0044] * * paragraphs [0054] , [0057] - [0059] * * paragraphs [0062] , [0064] , [0132] * [Y] 2,4,9,10; | [A]WO2009156137 (CSL BEHRING GMBH [DE], et al) [A] 1-16 * page 4, lines 12,13 * * page 4, line 32 * * page 6, lines 1-6 * * page 10, lines 24-32 * * page 12, lines 10-13 * * page 2, lines 24-27 ** page 3, line 6 *; | [XY]WO2011020866 (CSL BEHRING GMBH [DE], et al) [X] 1,3,5,6,8,11-16 * page 7, lines 10-20 * * page 7, lines 25-27 * [Y] 2,4,9,10; | [XY] - JERRY S POWELL ET AL, "Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients", BLOOD JOURNAL, (20120105), doi:10.1182/blood-2011-, XP055223058 [X] 1,3,5,6,8,11-16 * page 3031, column 2, paragraph 1 * * page 3032, column 1, paragraphs 1,2 * [Y] 2,4,9,10 DOI: http://dx.doi.org/10.1182/blood-2011-09-382846 | International search | [Y]US2009118185 (FAY PHILIP J [US], et al); | [Y]US2010285021 (JACQUEMIN MARC G [BE], et al); | [Y]WO2011069164 (BIOGEN IDEC INC [US], et al) |